THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
72 hedge funds and large institutions have $351M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
53% more funds holding
Funds holding: 47 → 72 (+25)
Holders
72
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$16.6M | |
| 2 | +$13.4M | |
| 3 | +$7.55M | |
| 4 |
VA
VR Adviser
New York
|
+$6.84M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.3M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$799K | |
| 3 | -$577K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$416K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$222K |